(NASDAQ: LMAT) Lemaitre Vascular's forecast annual revenue growth rate of 8.39% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.16%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.39%.
Lemaitre Vascular's revenue in 2024 is $193,484,000.On average, 4 Wall Street analysts forecast LMAT's revenue for 2024 to be $4,729,123,685, with the lowest LMAT revenue forecast at $4,712,259,087, and the highest LMAT revenue forecast at $4,735,489,792. On average, 5 Wall Street analysts forecast LMAT's revenue for 2025 to be $5,077,025,825, with the lowest LMAT revenue forecast at $4,929,823,571, and the highest LMAT revenue forecast at $5,251,479,482.
In 2026, LMAT is forecast to generate $5,426,223,522 in revenue, with the lowest revenue forecast at $5,376,567,891 and the highest revenue forecast at $5,454,748,147.